Your browser doesn't support javascript.
loading
Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.
Assi, Nada; Rinaldi, Sabina; Viallon, Vivian; Dashti, S Ghazaleh; Dossus, Laure; Fournier, Agnès; Cervenka, Iris; Kvaskoff, Marina; Turzanski-Fortner, Renée; Bergmann, Manuela; Boeing, Heiner; Panico, Salvatore; Ricceri, Fulvio; Palli, Domenico; Tumino, Rosario; Grioni, Sara; Sánchez Pérez, María José; Chirlaque, María-Dolores; Bonet, Catalina; Gurrea, Aurelio Barricarte; Amiano Etxezarreta, Pilar; Merino, Susana; Bueno de Mesquita, H Bas; van Gils, Carla H; Onland-Moret, Charlotte; Tjønneland, Anne; Overvad, Kim; Trichopoulou, Antonia; Martimianaki, Georgia; Karakatsani, Anna; Key, Tim; Christakoudi, Sofia; Ellingjord-Dale, Merete; Tsilidis, Kostas; Riboli, Elio; Kaaks, Rudolf; Gunter, Marc J; Ferrari, Pietro.
Afiliação
  • Assi N; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.
  • Rinaldi S; Biomarkers Group, International Agency for Research on Cancer (IARC), Lyon, France.
  • Viallon V; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.
  • Dashti SG; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.
  • Dossus L; Center for Epidemiology and Biostatistics, The University of Melbourne School of Population and Global Health, Parkville, VIC, Australia.
  • Fournier A; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.
  • Cervenka I; CESP, Fac. de Médecine, Univ. Paris-Sud, Fac. de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Kvaskoff M; Gustave Roussy, Villejuif, France.
  • Turzanski-Fortner R; Nutritional Epidemiology Group, International Agency for Research on Cancer (IARC), Lyon, France.
  • Bergmann M; CESP, Fac. de Médecine, Univ. Paris-Sud, Fac. de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Boeing H; Gustave Roussy, Villejuif, France.
  • Panico S; CESP, Fac. de Médecine, Univ. Paris-Sud, Fac. de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Ricceri F; Gustave Roussy, Villejuif, France.
  • Palli D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tumino R; Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
  • Grioni S; Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
  • Sánchez Pérez MJ; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • Chirlaque MD; Department of Clinical and Biological Sciences, University of Turin, Italy.
  • Bonet C; Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Italy.
  • Gurrea AB; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
  • Amiano Etxezarreta P; Cancer Registry and Histopathology Department, "Civic - M.P.Arezzo" Hospital, Ragusa, Italy.
  • Merino S; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Bueno de Mesquita HB; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • van Gils CH; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria, IBS GRANADA, Universidad de Granada, Granada, Spain.
  • Onland-Moret C; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Tjønneland A; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Overvad K; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.
  • Trichopoulou A; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain.
  • Martimianaki G; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Karakatsani A; Navarra Public Health Institute, Pamplona, Spain.
  • Key T; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Christakoudi S; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Ellingjord-Dale M; Public Health Division of Gipuzkoa, BioDonostia Research Institue, San Sebastian, Spain.
  • Tsilidis K; Public Health Directorate, Asturias, Spain.
  • Riboli E; Department of Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Kaaks R; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
  • Gunter MJ; Department of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
  • Ferrari P; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Int J Cancer ; 146(3): 759-768, 2020 02 01.
Article em En | MEDLINE | ID: mdl-30968961
ABSTRACT
Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex-hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol-consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol-related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor-positive tumors with respectively TE = 1.17(95%CI 1.01,1.35) and 1.36(1.08,1.70) for a 1-standard deviation (1-SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol-related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1-SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol-BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Consumo de Bebidas Alcoólicas / Pós-Menopausa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Consumo de Bebidas Alcoólicas / Pós-Menopausa Idioma: En Ano de publicação: 2020 Tipo de documento: Article